Tofidence™
Tofidence™ (tocilizumab-bavi) is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more Disease-Modifying Anti-Rheumatic Drugs (DMARDs).
Speak with your healthcare provider to learn if this drug is right for you.
WHAT IT TREATS: |
MANUFACTURER: Biogen MA Inc. |
CLASS: Interleukin-6 (IL-6) Blockers. |
PRESCRIBED BY: Rheumatologist
|
HOW ADMINISTERED: IV Infusion |
FREQUENCY: Every two to four weeks
|
Length of infusion: About 60 mins |
FOR MORE INFORMATION: |
